Virginia

Overview

Virginia legalized adult-use cannabis possession and home cultivation on July 1, 2021 via Senate Bill 1406, signed by Governor Ralph Northam; but the law did not authorize commercial retail sales. The state's medical cannabis program dates to 2018, when the Virginia State Board of Pharmacy approved the first dispensary-licensee applications. An earlier 1979 statute authorized physician cannabis recommendations for glaucoma and chemotherapy side effects but created no infrastructure.

In the 2026 legislative session, both chambers of the General Assembly approved a retail framework. Following bicameral reconciliation, Virginia is positioned for licensed commercial adult-use sales beginning January 1, 2027, taxed at a state rate of 6%. The Virginia Cannabis Control Authority is the designated regulator.

Adult-use (post-2021 possession; retail post-2027)

• Public possession: 1 oz or less of cannabis flower.
• Home cultivation: up to 4 plants per household (combined across resident adults).
• Commercial sales: illegal until January 1, 2027 (anticipated under the 2026 framework).
• Public consumption: prohibited in any space where tobacco smoking is restricted.

Medical program

Virginia's medical cannabis is dispensed through a pharmacist-led model. Pharmaceutical-grade products are dispensed at licensed pharmacies rather than through the cultivator-dispensary vertical-integration model used in most states.

Qualifying conditions

Since July 1, 2023, Virginia uses a physician-recommendation standard rather than a fixed enumerated list. Practitioners may recommend medical cannabis "for treatment or symptom relief" of any condition for which they believe the patient would benefit. Common diagnoses include cancer, epilepsy, glaucoma, MS, PTSD, chronic pain, Parkinson's disease, ALS, HIV/AIDS, and terminal-illness symptom management.

Patient access

• Possession: up to a 90-day supply as certified by the patient's registered practitioner.
• Approved forms: oils, tinctures, capsules, transdermal patches, gummies, vape cartridges. Smokable flower availability varies by dispensary.
• Home cultivation for patients: prohibited as a medical-program right, but patients may exercise the 4-plant-per-household adult-use cultivation right introduced in 2021.
• Reciprocity: Virginia does not formally recognize out-of-state medical cards.

Patients and caregivers

• Patient minimum age: no statutory floor. Minor patients require a designated caregiver and practitioner recommendation.
• Caregiver minimum age: 18 (verify against current Board of Pharmacy regulations).
• Caregivers per patient: typically up to 2 (verify).
• Caregiver registration: via the Virginia Board of Pharmacy; criminal background check.

Penalties

• Adult-use possession over 1 oz: civil penalty up to $25 for 1–4 oz; possession over 4 oz is a misdemeanor.
• Sale or distribution without license: felony, with penalties scaling by quantity per Va. Code § 18.2-248.1.

Patient registration steps

1. Schedule a visit with a Virginia-registered practitioner authorized to recommend cannabis. The registered practitioner must have completed a Board of Pharmacy training course and be on the active registry. Qualifying practitioners include physicians, nurse practitioners, and physician assistants.
2. The practitioner issues a written certification through the Virginia Board of Pharmacy patient portal.
3. The patient registers through the Board of Pharmacy portal, submits identity documents, proof of Virginia residency, and a current photo. The standard registration fee is $50; reduced fees apply for veterans and patients with documented financial hardship.
4. Approved patients receive a Virginia Cannabis Pharmacy Program ID. The ID authorizes purchases at any licensed Virginia cannabis pharmacy under the 90-day-supply framework.

Minor patients require a designated caregiver (parent or legal guardian) and a second practitioner's concurring recommendation. The caregiver completes a separate registration with the Board of Pharmacy and a Virginia State Police background check.

Pharmacist-led pharmacy model

Virginia's medical-cannabis framework is structurally distinct from the cultivator-dispensary vertical model used in most states:

• Licensure: the Virginia Board of Pharmacy licenses cannabis pharmacies. The Cannabis Control Authority regulates cultivation and processing.
• Staff: licensed pharmacists dispense product subject to professional review of the practitioner certification.
• Product: pharmaceutical-grade with required laboratory testing.
• Smokable flower: added to authorized forms in 2022; availability varies by pharmacy.

The pharmacist-led model provides clinical guidance on dosing, drug interactions, and product selection that is uncommon in standard dispensary settings. Virginia has only a handful of operating cannabis pharmacies statewide, distributed across five health-service-area regions.

Reciprocity and visiting patients

Virginia's framework is dual-track for visitors, with the adult-use track currently limited to possession (retail launching January 1, 2027):

• Adult-use possession: any visitor 21 or older may possess up to 1 oz under Va. Code §4.1-600 et seq.
• Adult-use purchase: not legally available from any Virginia retailer until January 1, 2027 (anticipated retail launch).
• Medical: Virginia does not formally recognize out-of-state medical cards. Visiting medical patients cannot purchase from Virginia cannabis pharmacies without Virginia practitioner certification.

Cross-border purchase from Maryland (adult-use legal since 2023), Washington DC (gray-market gifting framework), and West Virginia (medical only) shapes consumer flows pending Virginia's 2027 retail launch.

Employment and workplace

Virginia provides limited employment protections under the medical-cannabis statute and follow-on legislation:

• Medical patient discrimination: Va. Code §40.1-27.4 prohibits adverse employment action against an employee solely based on lawful medical cannabis use under the certified-patient framework, with carve-outs.
• Safety-sensitive positions: employers may continue to enforce drug-free workplace policies for safety-sensitive roles as defined by the employer.
• Federal contractor and DOT-regulated positions: federal drug-free workplace and DOT testing rules supersede state-level protection.
• Adult-use: no statutory employment protection for adult-use cannabis use as of mid-2026.
• Workers' compensation: post-incident testing positive for THC may affect benefits if impairment is established.

Public-employee positions, healthcare licensing, and CDL holders face additional licensing-board exposure. The 2027 retail launch and the 2026 framework legislation may include additional employment-protection provisions; current text is being finalized.

Hemp-derived intoxicants

Virginia enacted comprehensive restrictions on hemp-derived intoxicating cannabinoids through legislation in 2023 and 2024 (SB 903 and follow-on rulemaking). Delta-8 THC, delta-10 THC, THC-O, and similar compounds are restricted to retail channels licensed under the cannabis framework. Hemp-derived products with total THC above defined thresholds are not lawful for retail sale to consumers outside the licensed cannabis supply chain.

2027 retail launch framework

The 2026 General Assembly approved a commercial adult-use retail framework set to take effect January 1, 2027. Key elements:

• Tax structure: 6% state cannabis sales tax plus optional local-option tax.
• Licensing: vertically-integrated and standalone retailer licenses; social-equity license categories prioritizing applicants from disproportionately impacted areas.
• Regulator: Virginia Cannabis Control Authority (with continuing Board of Pharmacy authority over the medical-pharmacy framework).
• Existing medical pharmacies: authorized to convert to or expand into adult-use retail subject to dual-license requirements.
• Local opt-out: counties and municipalities may opt out of retail-cannabis business licensing within their jurisdiction by local ordinance or referendum.

The framework was the product of multi-year legislative work since the 2021 Northam-era possession legalization. Earlier 2022-2024 attempts at retail-launch authorization had failed under Governor Glenn Youngkin's preferences for tighter restrictions; the 2026 framework reflects negotiated compromises with the General Assembly.

Recent legislative history

Notable developments:

• 1979: earlier physician-recommendation statute for glaucoma and chemotherapy (no infrastructure).
• 2018: modern medical-cannabis framework approved; first dispensary licenses issued.
• 2021: SB 1406 legalized adult-use possession and home cultivation effective July 1.
• 2022: smokable flower added to authorized medical forms.
• 2023: physician-recommendation standard replaced enumerated conditions list effective July 1.
• 2024-2025: continued legislative work on retail framework, hemp-derived intoxicant restrictions.
• 2026: General Assembly approved retail framework effective January 1, 2027.

The April 2026 federal Schedule III rescheduling order produced limited immediate Virginia legislative response; the retail-framework work was already advanced.

Federal employment and military service

Virginia hosts the largest federal-employment population per capita of any US state, concentrated in the Navy, Marine Corps, Army, Air Force, and federal civilian intelligence community. Naval Station Norfolk (the largest naval base in the world), Joint Base Langley-Eustis, Marine Corps Base Quantico, Fort Belvoir, Fort Gregg-Adams (formerly Fort Lee), Naval Weapons Station Yorktown, NSA Hampton Roads, and Naval Air Station Oceana — combined with the Pentagon and the wider National Capital Region's federal-installation footprint — employ several hundred thousand active-duty service members, federal civilian staff, intelligence-community officers, and federal contractors. Federal cannabis prohibition applies to all of them regardless of Virginia state law.

Affected populations:

• Active-duty military: UCMJ Article 112a prohibits cannabis use regardless of state law. A positive THC test results in administrative or punitive discipline.
• Federal civilian employees: subject to federal drug-free workplace rules under 5 U.S.C. §7301. A positive THC test is grounds for adverse action.
• Security clearance holders: Security Executive Agent Directive 4 (SEAD 4) treats current cannabis use as a clearance concern regardless of state legality. The Northern Virginia intelligence and defense community sees this routinely.
• Federal contractors: Drug-Free Workplace Act of 1988 applies; drug-testing requirements often flow through subcontract chains common in Northern Virginia.
• CDL holders and other DOT-regulated employees: Department of Transportation 49 CFR Part 40 testing rules prohibit cannabis use; a positive test is disqualifying.

Virginia Code §40.1-27.4 provides limited protection for state employees from termination solely for off-duty medical cannabis use, but the protection does not extend to federal employment, federal contractor positions, or safety-sensitive roles defined by federal law. VA medical providers in Virginia cannot prescribe or recommend cannabis under federal VA policy, though VA benefits eligibility is not affected by lawful state-program participation. Informational only; not legal advice.

Federal context

Federal jurisdiction layers additional exposure on federal land, federal courthouses, military installations (Naval Station Norfolk, Joint Base Langley-Eustis, Marine Corps Base Quantico, Fort Belvoir, Fort Gregg-Adams (formerly Fort Lee), Naval Weapons Station Yorktown, NSA Hampton Roads, Naval Air Station Oceana), and interstate highways. Shenandoah National Park, George Washington and Jefferson National Forests, Colonial National Historical Park, and the federal District of Columbia border fall under federal jurisdiction where cannabis prohibition applies. I-64, I-66, I-77, I-81, I-85, I-95, and I-495 corridors see active state-patrol and federal drug-interdiction activity. The Pentagon and the wider National Capital Region's federal-installation footprint creates significant complexity for Northern Virginia patients and operators.